Aquestive Therapeutics annual return on equity
2019
Aquestive Therapeutics Return on Equity (ROE) Growth & History (AQST)
Aquestive Therapeutics's return on equity was −3,347.45% for fiscal 2019.
View full Aquestive Therapeutics company overviewAquestive Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | −3,347.45% | — |
Aquestive Therapeutics quarterly return on equity
Q4.18
Q1.19
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2019 | 2019-03-31 | −731.91% | — |
| Q4 2018 | 2018-12-31 | −83.19% | — |
Aquestive Therapeutics return on equity trends
The latest reported quarter, Q1 2019, shows −731.91%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aquestive Therapeutics source filings ↗